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Abstract
Background: In chronic obstructive pulmonary disease (COPD) patients, functional and struc-
tural changes of the respiratory system greatly influence cardiovascular autonomic functions.
Determining autonomic balance may be important in understanding the pathophysiology of COPD
and useful clinically in the treatment of COPD patients. Heart rate variability (HRV) and heart
rate turbulence (HRT) are useful tools in assessing the autonomic neurovegetative function. Our
aim in this study was to evaluate the HRV and HRT variables in COPD patients. Twenty five
moderate to severe COPD patients and 25 healthy subjects were included in this study.
Methods: Pulmonary function tests and echocardiographic examination, arterial blood gases
analysis were performed, HRV and HRT analysis were assessed from a 24-hour Holter recording.
Results: When HRV and HRT parameters were compared, COPD patients had significantly
decreased sNN50 total, pNN50, SDANN, SDNN, SDNNI, rMSDD in time domain HRV param-
eters, and the values of the HRT onset was significantly less negative in COPD patients. Although
the values of the HRT slope were lower in COPD patients, there was no significant difference
between the two groups. We also found a correlation between HRT and HRV parameters.
Conclusions: In addition to HRV parameters, HRT onset was significantly different in
COPD patients. In our opinion, the combination of HRV variables and HRT onset may be
simple and elegant ways of evaluating cardiac autonomic functions. New investigations of
HRT and HRV in COPD patients have a potential importance for improving risk stratification
and therapeutic approaches, and understanding the autonomic outcomes of the disease process.
(Cardiol J 2009; 16, 6: 553–559)
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Introduction
Chronic obstructive pulmonary disease
(COPD) is a complex and heterogeneous clinical
syndrome found in 6–8% of the entire population [1].
In COPD patients, functional and structural changes
of the respiratory system deeply influence cardio-
vascular function [2].
Cardiac arrhythmia and sudden death are com-
mon and important causes of mortality in patients
with COPD. Several factors such as abnormal auto-
nomic control of cardiopulmonary function may con-
tribute to the development of arrhythmias in these
patients [3–6]. Determination of autonomic balance
may be important in understanding the pathophy-
siology of COPD and might be useful clinically in
the treatment of patients with COPD [7].
Despite its importance in determining mortal-
ity and pathogenesis of the disease there are also
some contrary reports about the relation between
autonomic dysfunction and COPD [8–12].  It is
known that cardiac autonomic functions can be
quantified by measuring beat-to-beat variability of
the heart rate recorded during 24-hour electrocar-
diography (ECG) monitoring [13].
Heart rate variability (HRV) analysis has been
used as a predictor of sudden cardiac death or as
a marker of the progression of cardiovascular disease
in several high-risk populations, and it is a useful
tool in assessing the autonomic neurovegetative
function [13]. Though there are some reports on
changes in time-domain and frequency-domain
heart rate variability in COPD patients, the infor-
mation on HRV in patients with COPD has so far
been conflicting [8, 11, 14–16]. Heart rate turbu-
lence (HRT), which reflects a response of heart rate
to a premature ventricular beat, has been intro-
duced as a new noninvasive tool for risk stratifica-
tion. The disappearance of HRT implicates the loss
of normal autonomic nervous regulation [17]. But
no study has until now been published which inves-
tigated HRT variables in COPD patients.
The aim of this study was to evaluate the pres-
ence of autonomic dysfunction in patients with
COPD by HRV and HRT analysis and to determine
whether the parameters of HRV and HRT in this
population are different from the normal population.
Methods
Patients
Twenty five (22 male, 3 female, mean age: 63 ±
± 7 years) clinically stable, ambulatory, and mode-
rate to severe COPD patients were included in this
study. The diagnosis of COPD and its severity were
determined according to the GOLD criteria [18].
The control group also consisted of 25 age-matched
healthy volunteer subjects (19 male, 6 female, mean
age: 60 ± 8 years).
Patients were excluded who were ischemic, had
rheumatic heart disease, cardiac failure, diabetes
mellitus, thyroid disorders, central or peripheral nerv-
ous system diseases and pathologies, electrolyte im-
balance, body mass index ≥ 30 kg/m2, a history of al-
cohol abuse or taking drugs that affect the heart rate.
The present study was a single center study.
All examinations were performed by cardiology and
pneumonology outpatient clinics in Izzet Baysal
University Hospital from November 2005 to March
2007. The patients and the controls gave their in-
formed consent prior to inclusion in the study. The
study protocol was approved by the ethics commit-
tee at our institution.
Experimental procedures
Pulmonary function test. All participants
underwent spirometric pulmonary function per-
formed in accordance with American Thoracic So-
ciety guidelines. Pulmonary function tests were
performed by a spirometer (Spirolab MIR, Italy),
and force vital capacity (FVC), force expiratory vo-
lume 1 (FEV1), FEV1/FVC were measured. Arte-
rial puncture was performed only on COPD patients.
Arterial blood gases were determined from samples
obtained while breathing room air by puncturing the
radial artery with the patient seated, and arterial
oxygen saturation (SaO2), PaO2, PaCO2, pH, and
HCO3 were analyzed. The patients were asked not
to take bronchodilators for the 12 hours before the
tests. Inhaled corticosteroids were allowed in the
same dosage as those already being taken.
Echocardiography. An experienced echocar-
diographer assessed the echocardiography studies.
Echocardiographic examination was carried out
with Vingmed Vivid 3 (General Electric, Vingmed
Ultrasound, Israel) echocardiographic system
equipped with 2.5–3.5 MHz transducers. M-mode
and 2-dimensional (2-D) measurements were done
in accordance with methods recommended by the
American Society of Echocardiography, using all
standard echocardiographic windows. Following
M-mode and 2-D assessment of morphology, a tri-
cuspid regurgitation systolic jet was recorded from
the parasternal or apical window with the continu-
ous-wave Doppler probe. Systolic right ventricular
(or pulmonary artery) pressure (PAP) was calculat-
ed using the modified Bernoulli equation given by:
PAP = 4 × (tricuspid systolic jet)2 + 10 mm Hg (es-
timated right atrial pressure). Pulmonary hyperten-
sion was defined as a systolic PAP ≥ 35 mm Hg.
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Holter analysis. All patients and controls
underwent 24-hour Holter monitoring. All patients
were in sinus rhythm throughout the recording
period. Holter ECGs were analyzed using the Del
Mar Reynolds Pathfinder Holter system. One of our
authors, blinded to the diagnosis of the patients,
conducted the analyses of Holter ECGs.
The HRV analysis was assessed over a 24-hour
period and was performed in time domains accord-
ing to European Society of Cardiology/North Ameri-
can Society of Pacing and Electrophysiology guide-
lines. The following time-domain parameters were
calculated: mean of all normal RR intervals (mean
RR); standard deviations of all NN intervals
(SDNN); mean of the standard deviations of all NN
intervals for all 5-minute segments of the entire
recording (SDNNI); standard deviation of the aver-
ages of NN intervals in all 5-minute segments of the
entire recording (SDANN); the square root of the
mean of the sum of the squares of differences be-
tween adjacent NN intervals (rMSSD); count of the
total number of differences between adjacent RR
intervals that were greater than 50 ms (sNN50 to-
tal); the number of pairs of adjacent NN intervals
differing by more than 50 ms divided by the total
number of all NN intervals (pNN50).
HRT parameters were calculated according to
the original method reported by Schmidt et al. [19]
Two numerical descriptors were estimated: turbu-
lence onset reflecting the initial phase of sinus
rhythm acceleration and turbulence slope describ-
ing deceleration phase. Heart rate turbulence on-
set (HRT onset) was defined as the difference be-
tween the mean of the first two sinus-rhythm RR
intervals following the compensatory pause after
a premature ventricular complex (PVC) and the
mean of the last two sinus-rhythm RR intervals pre-
ceding the PVC, expressed as a percentage of the
former. Heart rate turbulence slope (HRT slope)
was defined as the maximum positive slope of a re-
gression line assessed over any sequence of five
subsequent sinus-rhythm RR intervals within
the first 20 sinus-rhythm intervals after PVC, ex-
pressed as ms/beat. The HRT onset or slope was
defined as abnormal if the onset was £ 2.5 ms/beat.
Patients with atrial fibrillation or without PVC
and clinically relevant dysrhythmias or ECG chang-
es potentially interfering with the accurate meas-
urements of HRV and HRT were excluded.
Statistical analysis
Statistical analysis was performed using the
Statistical Package for Social Sciences (SPSS, Chi-
cago, IL, USA), version 11.0 software for Windows.
Descriptive statistics were made and all data was
expressed as mean ± standard deviation and per-
centage ratio. The quantitative values between the
two groups were compared using Student’s t-test,
and the qualitative values were compared using the
c2 test. Correlations between HRT and HRV param-
eters and the other parameters such as pulmonary
function test and blood gas analysis and echocardio-
graphic results were assessed using Spearman’s
rank correlation test. P value of < 0.05 was consid-
ered statistically significant in all cases.
Results
Twenty five (22 male, 3 female, mean age: 63 ±
± 7 years) COPD patients and 25 healthy subjects
(19 male, 6 female, mean age: 60 ± 8 years) were
included in this study. Age, sex, presence of hyper-
tension, body mass index, prevalence of ventricu-
lar premature contraction (VPC), mean heart rate,
mean RR were not significantly different between
two groups. However, smoking prevalence was sig-
nificantly higher in COPD patients than in control
group. The data are shown in Tables 1 and 2.
There were significant differences in the
parameters of pulmonary function test such as
FVC, FEV1 and FEV1/FVC ratio between COPD
patients and the healthy group (p < 0.001) as given
in Table 1.
Table 1. Demographic characteristics and results
of respiratory function tests, arterial blood gas
analyses of COPD patients and control group.
Variables COPD Control p
(n = 25) (n = 25)
Demographic characteristics
Age (years) 63±7 60±8 0.164
Gender (M/F) 22/3 19/6 0.339
Hypertension (%) 18 16 0.161
BMI [kg/m2] 24.9±2.9 24.8±3.7 0.577
Smoking (%) 100 64 < 0.001
Pulmonary function test parameters
FVC (%) 59±15 96±5 < 0.001
FEV1 (%) 44±15 98±7 < 0.001
FEV1/FVC 58±9 80±9 < 0.001
Arterial blood gas analysis
pH 7.40±0.02
PO2 [mm Hg] 68±13
PCO2 [mm Hg] 41±7
SaO2 (%) 91±5
COPD — chronic obstructive pulmonary disease; BMI — body mass
index; FVC — force vital capacity; FEV1 — force expiratory volume 1;
SaO2 — arterial oxygen saturation
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On echocardiographic examination, COPD pa-
tients had increased right ventricular internal diam-
eter (diastolic), right atrium diameter and PAP com-
pared to controls. However, interventricular wall
thickness, left ventricular posterior wall thickness,
left ventricular internal diameter (sistolic and dia-
stolic), left atrial diameter, and ejection fraction
were similar between COPD patients and controls.
The echocardiographic characteristics of the two
groups are given in Table 3.
Heart rate variability analysis revealed that
COPD patients had decreased sNN50 total, pNN50,
SDANN, SDNN, SDNNI, RMSDD in time domain
parameters (Table 2).
When HRT parameters were compared, the
values of the HRT onset was significantly less ne-
gative in COPD patients than the control group
(–0.010 ± 0.032 vs. –0.165 ± 0.219%, p = 0.03).
Although the values of the HRT slope were lower
in patients with COPD than the control group, there
was no significant difference between the two
groups. When dichotomizing patients according to
abnormal values (HRT onset > 0% and HRT slope
< 2.5 ms/RR) as proposed by Schmidt et al. [19],
the number of patients who had abnormal HRT
onset and HRT slope were not significantly differ-
ent between the two groups. Table 2 summarizes
the HRT and HRV parameters in COPD and con-
trol patients.
When the correlation between HRT and HRV
parameters was evaluated, we observed a signifi-
cant correlation. A negative correlation between
HRT onset and SDANN, rMSDD (r = –0.357, p =
= 0.011, and r = –0.457, p = 0.001, respectively)
and a positive correlation between HRT slope and
sNN50 total, pNN50, SDNN, SDANN (r = 0.359,
Table 3. Comparisons of echocardiographic
results of COPD patients and control group.
Variables COPD Control p
(n = 25)  (n = 25)
IVSd [mm] 10±2 8±3 NS
LVPWd [mm] 11±3 9±2 NS
LVIDd [mm] 53±4 49±6 NS
LVISd [mm] 32±3 30±4 NS
LVEF (%) 64±7 65±7 NS
LA diameter [mm] 34±8 30±9 NS
RA diameter [mm] 36±5 32±7 NS
RV wall thickness [mm] 11±2 7±3 < 0.01
RV diameter [mm] 30±6 21±4 < 0.01
PAP [mm Hg] 32±12 24±6 < 0.01
COPD — chronic obstructive pulmonary disease; IVSd — interventri-
cular septum diastolic diameter; LVPWd — left ventricular posterior
wall diastolic diameter; LVIDd — left ventricular internal diastolic
diameter; LVISd — left ventricular internal diastolic diameter;
LVEF — left ventricular ejection fraction; LA — left atrial;
RA — right atrial; RV — right ventricular; LV — left ventricular;
PAP — pulmonary artery pressure
Table 2. Comparison of Holter recordings, heart rate variability (HRV) and heart rate turbulence (HRT)
parameters between patients with chronic obstructive pulmonary disease (COPD) and control subjects.
Variables COPD (n = 25) Control subjects (n = 25) p
Mean heart rate [beats/min] 73±9 70±8 NS
Mean RR 798±85 764±100 NS
VPC count per day 689±367 283±163 NS
HRT parameters
HRT onset (%) –0,010±0.032 –0,165±0.219 0.03
HRT slope [ms/beat] 6.0±3.6 8.1±4.4 NS
Abnormal HRT onset 6 (24%) 3 (12%) NS
Abnormal HRT slope 2 (8%) 3 (12%) NS
HRV parameters
sNN50 total 7965±8320 23875±15917 < 0.05
pNN50 (%) 11.8±9.4 15.7±8.1 < 0.05
SDNN [ms] 111±34 141±25 < 0.001
SDNNI [ms] 51±21 73±16 < 0.01
SDANN [ms] 84±19 120±24 < 0.01
rMSDD [ms] 25±10 60±35 < 0.01
VPC — ventricular premature contraction; SDNN — standard deviations of all NN intervals; SDNNI — mean of the standard deviations of all NN
intervals for all 5-minute segments of the entire recording; SDANN — standard deviation of the averages of NN intervals in all 5-minute segments
of the entire recording; rMSSD — the square root of the mean of the sum of the squares of differences between adjacent NN intervals; sNN50 total
— total count of the total number of differences between adjacent RR intervals that were greater than 50 ms; pNN50 — the number of pairs of adjacent
NN intervals differing by more than 50 ms divided by the total number of all NN intervals
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p = 0.011; r = 0.213, p = 0.002; r = 0.355, p = 0.011,
and r = 0.320, p = 0.024, respectively) were re-
vealed (Table 4).
In addition, we evaluated the correlation be-
tween HRT parameters and pulmonary function test
(FVC%, FEV1%, FEV1/FVC) and arterial blood gas
analysis (pH, PO2, PCO2, SaO2) and echocardio-
graphic (especially left ventricular ejection fraction)
results. There was only a significant correlation
between HRT onset, HRT slope and FEV1/FVC
(r = –0.481, p = 0.017; r = 0.489, p = 0.03, respec-
tively). The correlation between HRT parameters
and the other parameters were not significiant.
Discussion
Cardiac arrhythmias are common in COPD
patients. A poor prognosis has been noted in asso-
ciation with these arrhythmias, particularly ven-
tricular arrhythmias. It is known that cardiac auto-
nomic dysfunction, which is known to be disturbed
in COPD patients, is important in the development
of arrhythmias. In addition, it is likely that abnor-
mal activity of autonomic nerve innervations can
contribute to airway narrowing in COPD, and may be
relevant to the pathogenesis of COPD [3, 10, 20–26].
Unfortunately, the actual autonomic tone of the air-
ways is difficult to detect non-invasively in these
patients. But it is well known that HRV measure-
ment provides a non-invasive assessment of cardi-
ovascular autonomic functions [13, 27].
By using spectral HRV analysis, Volterrani
et al. [8] found that COPD patients had abnormal
autonomic nervous function, with, in particular,
a depressed HRV response to sympathetic and va-
gal stimuli. The correction of hypoxemia can par-
tially reverse these abnormalities [9]. In the present
study, HRV analysis from 24 hours ambulatory ECG
recordings showed that there were marked differ-
ences in time domain indices (SNN50 total, pNN50,
SDNN, SDNNI, SDANN and rMSDD) between the
COPD patients and control groups. These results
are consistent with previous observations that au-
tonomic nervous dysfunction exists in COPD [8–10].
The complexity of the pulmonary effects of the
autonomic nervous system is considerable, and our
knowledge remains elementary, with little known
about the prognostic value of HRV in patients with
COPD [8, 25].
HRT, a new heart rate derived parameter
tracking the response of the heart rate to ventricu-
lar arrhythmias, was introduced into electrocardi-
ology in 1999 as a strong predictor of mortality in
post-infarction patients, and it can be used as a non-
invasive measure of cardiac autonomic dysfunction
[19]. The last few years have brought an increas-
ing interest in the analysis of both clinical correla-
tions and the predictive value of this parameter in
different subsets of patients. Compared to other
non-invasive risk predictors, the relative risk and
positive predictive accuracy of HRT are slightly
better [17]. But, no study has until now been pub-
lished which investigated HRT variables in COPD
patients.
In our study, in addition to HRV parameters,
HRT onset was significantly different in COPD pa-
tients. HRT slope was shorter in COPD patients
than in control patients. However, this finding did
not reach statistical significance, and might result
from the number of our cases being relatively low.
Correlations between HRT and HRV parame-
ters have been observed in large populations of
patients after myocardial infarction (EMIAT and
ATRAMI studies) [28–31]. In one study, HRT slope
and HRT onset were found to correlate significant-
ly with almost all heart rate variability time domain
parameters, including SDNN, heart rate variability
index, TINN, and rMSSD. HRT onset also corre-
lates with pNN50 [32]. Two other studies confirmed
a significant correlation between HRT and time
domain HRV in patients with diabetes mellitus or
dilated cardiomyopathy [33, 34]. In the present
study, we also found a negative correlation between
HRT onset and SDANN, rMSDD and a positive
correlation between HRT slope and sNN50 total,
pNN50, SDNN, SDANN. According to our results,
HRT parameters were correlated with HRV param-
eters, indicating that HRT and HRV should be con-
sidered as reflections of overall autonomic tone in
COPD patients.
As a result, in our opinion, the combination of
HRV and HRT (especially HRT onset) variables
Table 4. Correlation analysis between heart
rate variability (HRV) parameters and heart
rate turbulence (HRT) onset, HRT slope.
Parameters HRT onset HRT slope
r p r p
sNN50 total –0.201 NS 0.359 0.011
pNN50 (%) –0.311 NS 0.213 0.002
SDNN [ms] –0.241 NS 0.355 0.011
SDNNI [ms] –0.085 NS 0.254 NS
SDANN [ms] –0.357 0.011 0.320 0.024
rMSDD [ms] –0.457 0.001 0.210 NS
Abbreviations: see Table 2
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may be simple and elegant ways of evaluating car-
diac autonomic functions. Such a combination  may
increase the positive predictivity and lead to a more
accurate identification of high risk patients, more
aggressive treatment toward preventing sudden
death and/or preventing progression of disease to
mortality. Therefore, new investigations of HRT
and HRV in patients with COPD have a potential
importance for improving risk stratification and
therapeutic approaches, and understanding the au-
tonomic outcomes of the disease process.
Limitations of the study
This study is a single center, observational and
comparative study and the number of cases includ-
ed is relatively low. Presumably, a larger study
population will be necessary to obtain more definite
evidence to determine the relationship between
HRT, HRV variables and the presence of COPD.
Because our Holter device (Del Mar Reynolds
Pathfinder Holter system) analyzes only time do-
main parameters, we couldn’t measure frequency
domain parameters of HRV. But it has been men-
tioned that each of the 24-hour frequency domain
spectral measures has an equivalent time domain
variable, which is highly correlated with it because
both are influenced by the same physiologic inputs
and because of mathematical relationships [13, 35].
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